KR20130026513A - IgA1 침착 질환 치료 - Google Patents

IgA1 침착 질환 치료 Download PDF

Info

Publication number
KR20130026513A
KR20130026513A KR1020137005608A KR20137005608A KR20130026513A KR 20130026513 A KR20130026513 A KR 20130026513A KR 1020137005608 A KR1020137005608 A KR 1020137005608A KR 20137005608 A KR20137005608 A KR 20137005608A KR 20130026513 A KR20130026513 A KR 20130026513A
Authority
KR
South Korea
Prior art keywords
asn
iga1
thr
ser
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137005608A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 지. 플라우스
지아자우 퀴우
Original Assignee
뉴 잉글랜드 메디컬 센터 호스피털스 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뉴 잉글랜드 메디컬 센터 호스피털스 인코퍼레이티드 filed Critical 뉴 잉글랜드 메디컬 센터 호스피털스 인코퍼레이티드
Publication of KR20130026513A publication Critical patent/KR20130026513A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
KR1020137005608A 2003-03-07 2004-03-05 IgA1 침착 질환 치료 Ceased KR20130026513A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45305503P 2003-03-07 2003-03-07
US60/453,055 2003-03-07
PCT/US2004/006615 WO2004096157A2 (en) 2003-03-07 2004-03-05 Treatment of igai deposition diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020057016464A Division KR20060015468A (ko) 2003-03-07 2004-03-05 IgA1 침착 질환 치료

Publications (1)

Publication Number Publication Date
KR20130026513A true KR20130026513A (ko) 2013-03-13

Family

ID=33418058

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137005608A Ceased KR20130026513A (ko) 2003-03-07 2004-03-05 IgA1 침착 질환 치료
KR1020057016464A Ceased KR20060015468A (ko) 2003-03-07 2004-03-05 IgA1 침착 질환 치료

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020057016464A Ceased KR20060015468A (ko) 2003-03-07 2004-03-05 IgA1 침착 질환 치료

Country Status (10)

Country Link
US (3) US7407653B2 (https=)
EP (1) EP1603511B1 (https=)
JP (4) JP5438886B2 (https=)
KR (2) KR20130026513A (https=)
CN (1) CN1777673B (https=)
AT (1) ATE496992T1 (https=)
CA (1) CA2558873C (https=)
DE (1) DE602004031199D1 (https=)
ES (1) ES2360291T3 (https=)
WO (1) WO2004096157A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603511B1 (en) * 2003-03-07 2011-01-26 New England Medical Center Hospitals, Inc. Treatment of igai deposition diseases
WO2007061936A2 (en) 2005-11-18 2007-05-31 New England Medical Center Hospitals, Inc. Clearance of abnormal iga1 in iga1 deposition diseases
US20080027554A1 (en) * 2006-07-31 2008-01-31 Talmadge Karen D Kit and methods of treatment of an intervertebral disc
TW201040266A (en) * 2009-04-10 2010-11-16 Biomarin Pharm Inc Methods of enhancing yield of active IgA protease
US8841109B2 (en) 2009-04-20 2014-09-23 The University Of Kansas IGA1 protease polypeptide agents and uses thereof
CN104073474A (zh) * 2014-06-27 2014-10-01 樊均明 一种IgA1酶及其制备方法和应用
WO2017223534A2 (en) * 2016-06-24 2017-12-28 Anthera Pharmaceuticals, Inc. Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor
CN115197328B (zh) * 2021-04-09 2025-05-16 北京大学第一医院 一种可清除体内免疫球蛋白A的重组融合蛋白酶及其制备方法和在治疗IgA肾病中的应用
JP2025505131A (ja) * 2022-01-29 2025-02-21 ペキン ユニバーシティ ファースト ホスピタル IgAプロテアーゼトランケート、IgAプロテアーゼトランケートを含む融合タンパク質及びその用途
KR20250114034A (ko) 2022-11-11 2025-07-28 아이간 바이오사이언스 Iga 프로테아제 폴리펩타이드 제제
JP7736395B1 (ja) * 2024-02-29 2025-09-09 積水メディカル株式会社 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、免疫学的測定用試薬キット、及び非特異反応抑制剤
WO2025237369A1 (en) * 2024-05-15 2025-11-20 Shanghai Alezyme Pharmaceuticals Ltd. Conjugates comprising iga protease or variants thereof and a polyethylene glycol moiety, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
US6429024B1 (en) * 1998-03-31 2002-08-06 Asahi Kasei Kabushiki Kaisha Test method for IgA nephropathy
DK2067788T3 (da) 1999-05-18 2015-10-19 Dyax Corp Fab-fragmentbiblioteker og fremgangsmåder til anvendelse deraf
EP1603511B1 (en) 2003-03-07 2011-01-26 New England Medical Center Hospitals, Inc. Treatment of igai deposition diseases

Also Published As

Publication number Publication date
CN1777673A (zh) 2006-05-24
US20090041746A1 (en) 2009-02-12
HK1090950A1 (zh) 2007-01-05
ES2360291T3 (es) 2011-06-02
JP2011101645A (ja) 2011-05-26
US20090130084A1 (en) 2009-05-21
JP2006519619A (ja) 2006-08-31
US8216568B2 (en) 2012-07-10
JP2015096079A (ja) 2015-05-21
EP1603511B1 (en) 2011-01-26
US7407653B2 (en) 2008-08-05
JP5438886B2 (ja) 2014-03-12
EP1603511A4 (en) 2007-06-06
JP2013230157A (ja) 2013-11-14
KR20060015468A (ko) 2006-02-17
CA2558873A1 (en) 2004-11-11
US20050136062A1 (en) 2005-06-23
DE602004031199D1 (de) 2011-03-10
WO2004096157A3 (en) 2005-10-20
ATE496992T1 (de) 2011-02-15
WO2004096157A2 (en) 2004-11-11
CA2558873C (en) 2015-10-20
CN1777673B (zh) 2010-04-28
EP1603511A2 (en) 2005-12-14

Similar Documents

Publication Publication Date Title
US8216568B2 (en) Combination therapy with IgA1 proteases
CN100516220C (zh) 双岐杆菌的丝氨酸蛋白酶抑制剂
WO1997008553A1 (en) Targeting of proteins to the cell wall of gram-positive bacteria
Garrigues et al. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s
JPH10505752A (ja) システイン・プロテアーゼあるいはその断片を含む連鎖球菌を識別するための方法および組成物
KR20080052527A (ko) 외표면 단백질들, 그들의 유전자들 및 그들의 사용
JPH10512439A (ja) 新規ポリペプチド
JP2001521750A (ja) 黄色ブドウ球菌のmurdタンパク質およびmurd遺伝子
HK1090950B (en) Treatment of iga1 deposition diseases
CA3195929A1 (en) Compositions and methods for treating celiac sprue disease
CN120136979B (zh) 一种靶向结合PCNA蛋白的binder、融合蛋白及其应用
Manrique Treball Final de Grau
KR20200002654A (ko) Pd-1과 결합력이 증가된 pd-l1 변이체
JP2025537294A (ja) IgAプロテアーゼポリペプチド剤
WO2026037258A1 (zh) 具有改善的热稳定性的分选酶
HK40098968A (zh) 一对用於编辑人pcsk9核酸序列的辅助引导rna/引导rna
WO1999009145A1 (en) Identification of sortase gene
Mo The HtrA family of proteins in Salmonella typhimurium and Staphylococcus aureus
Mo Analysis of the HtrA family of proteins in salmonella typhimurium and staphyococcus aureus
JP2001521735A (ja) 化膿連鎖球菌のmurdタンパク質およびmurd遺伝子
Autocatalysis The Metalloprotease of

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20130304

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130403

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130604

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140410

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150528

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20140410

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20130604

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I